Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak

 Preference of women is increasing toward popular pregnancy care products as compared to the traditional methods for skincare and this is influencing the growth. The rise in the awareness among people about safe and effective skincare products after and during pregnancy is driving the growth of the global pregnancy care products. Less adoption of advanced pregnancy care products in underdeveloped countries and use of chemicals in manufacturing of pregnancy care products like retinol, salicylic acid and toluene are restraining the global pregnancy care products market.

Pregnancy care products help in preventing issues due to pregnancy like stretch marks, skin irritation and leg pain. These products provide nutrition to body and remove the unwanted oil. Pregnancy care products decrease the risk for certain birth defects.

There are physical changes in women due to pregnancy, because of which there is a need of pregnancy care products such as stretch marks cream and others. The increase in the pregnancy rate globally is also one of the factors influencing the global pregnancy care products market growth. Technological advancements in the pregnancy care products and distribution channel are also driving the growth. Stretch mark minimizer helps the women to reduce their marks after pregnancy and is driving the growth. Skin issues due to pregnancy like sore breasts, skin irritation and leg pain, are fueling the pregnancy care product market.

COVID-19 Scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. 

Companies covered

Mama Mio U.S. Inc., Nine Naturals, Clarins Group, LLC., Novena Maternity, Expanscience Laboratories, E.T. Browne Drug Co., Noodle & Boo., Mustela Procter & Gamble and Mankind Pharma